...
camp-img

CAMP4 THERAPEUTICS CORPORATION, Common Stock

CAMP

NMQ

$6.9

-$0.68

(-8.97%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$0
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.06 L
$12.3 H
$6.9

About CAMP4 THERAPEUTICS CORPORATION, Common Stock

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue308.59M295.84M294.95M186.23M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.87,"profit":true},{"date":"2022-12-31","value":95.58,"profit":true},{"date":"2023-12-31","value":60.35,"profit":true}]
Cost of Revenue186.18M173.95M185.94M119.25M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":93.43,"profit":true},{"date":"2022-12-31","value":99.87,"profit":true},{"date":"2023-12-31","value":64.05,"profit":true}]
Gross Profit122.41M121.89M109.01M66.98M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.58,"profit":true},{"date":"2022-12-31","value":89.06,"profit":true},{"date":"2023-12-31","value":54.72,"profit":true}]
Gross Margin39.67%41.20%36.96%35.97%[{"date":"2020-12-31","value":96.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.71,"profit":true},{"date":"2023-12-31","value":87.3,"profit":true}]
Operating Expenses125.87M134.76M129.11M75.70M[{"date":"2020-12-31","value":93.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.81,"profit":true},{"date":"2023-12-31","value":56.18,"profit":true}]
Operating Income(3.87M)(15.31M)(21.48M)(8.72M)[{"date":"2020-12-31","value":-386900000,"profit":false},{"date":"2021-12-31","value":-1531300000,"profit":false},{"date":"2022-12-31","value":-2148200000,"profit":false},{"date":"2023-12-31","value":-872100000,"profit":false}]
Total Non-Operating Income/Expense--(8.95M)(81.21M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-895300000,"profit":false},{"date":"2023-12-31","value":-8120700000,"profit":false}]
Pre-Tax Income(20.60M)(30.06M)(31.34M)(92.74M)[{"date":"2020-12-31","value":-2059600000,"profit":false},{"date":"2021-12-31","value":-3006100000,"profit":false},{"date":"2022-12-31","value":-3133900000,"profit":false},{"date":"2023-12-31","value":-9273600000,"profit":false}]
Income Taxes561.00K1.09M1.15M(525.00K)[{"date":"2020-12-31","value":48.74,"profit":true},{"date":"2021-12-31","value":94.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-45.61,"profit":false}]
Income After Taxes--(32.49M)(92.21M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3249000000,"profit":false},{"date":"2023-12-31","value":-9221100000,"profit":false}]
Income From Continuous Operations--(44.19M)(49.29M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4419200000,"profit":false},{"date":"2023-12-31","value":-4929100000,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(21.16M)(31.15M)(32.49M)(93.26M)[{"date":"2020-12-31","value":-2115700000,"profit":false},{"date":"2021-12-31","value":-3114800000,"profit":false},{"date":"2022-12-31","value":-3249000000,"profit":false},{"date":"2023-12-31","value":-9326100000,"profit":false}]
EPS (Diluted)----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CAMP
Current Ratio 1.90

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CAMP
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CAMP
Debt Ratio Lower is generally better. Negative is bad. 5.91
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -4.91

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CAMP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is CAMP4 THERAPEUTICS CORPORATION share price today?

CAMP4 THERAPEUTICS CORPORATION (CAMP) share price today is $6.9

Can Indians buy CAMP4 THERAPEUTICS CORPORATION shares?

Yes, Indians can buy shares of CAMP4 THERAPEUTICS CORPORATION (CAMP) on Vested. To buy CAMP4 THERAPEUTICS CORPORATION from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CAMP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of CAMP4 THERAPEUTICS CORPORATION be purchased?

Yes, you can purchase fractional shares of CAMP4 THERAPEUTICS CORPORATION (CAMP) via the Vested app. You can start investing in CAMP4 THERAPEUTICS CORPORATION (CAMP) with a minimum investment of $1.

How to invest in CAMP4 THERAPEUTICS CORPORATION shares from India?

You can invest in shares of CAMP4 THERAPEUTICS CORPORATION (CAMP) via Vested in three simple steps:

  • Click on Sign Up or Invest in CAMP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in CAMP4 THERAPEUTICS CORPORATION shares
What is CAMP4 THERAPEUTICS CORPORATION 52-week high and low stock price?

The 52-week high price of CAMP4 THERAPEUTICS CORPORATION (CAMP) is $12.3. The 52-week low price of CAMP4 THERAPEUTICS CORPORATION (CAMP) is $4.06.

What is CAMP4 THERAPEUTICS CORPORATION price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of CAMP4 THERAPEUTICS CORPORATION (CAMP) is

What is CAMP4 THERAPEUTICS CORPORATION price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of CAMP4 THERAPEUTICS CORPORATION (CAMP) is 0.00

What is CAMP4 THERAPEUTICS CORPORATION dividend yield?

The dividend yield of CAMP4 THERAPEUTICS CORPORATION (CAMP) is 0.00%

What is the Market Cap of CAMP4 THERAPEUTICS CORPORATION?

The market capitalization of CAMP4 THERAPEUTICS CORPORATION (CAMP) is

What is CAMP4 THERAPEUTICS CORPORATION’s stock symbol?

The stock symbol (or ticker) of CAMP4 THERAPEUTICS CORPORATION is CAMP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top